GlaxoSmithKline
GlaxoSmithKline (GSK) is a research-based pharmaceutical company whose mission is to improve the quality of human life by enabling people to do more, feel better and live longer. GSK is the only pharmaceutical company to tackle the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria.
AMREF and GSK
Zingatia Maisha! (Carefully Consider Life)
In Kenya, AMREF with support from GlaxoSmithKline, is working to break down the barriers that prevent those infected with HIV/AIDS accessing the care and support that they need. Click here to find out more.
PHASE
GSK is also supporting AMREF to improve hygiene and sanitation for thousands of schoolchildren in Kenya and Uganda and around the world. Click here to find out more.
Uganda Malaria Partnership Programme
In Uganda, GlaxoSmithKline has supported AMREF to reduce malaria-related deaths by educating communities about the causes and symptoms of malaria and training community medicine distributors to provide treatment close to people’s homes.
“GSK’s partnership with AMREF dates back to the early 1980s. For almost 25 years we have worked together to tackle complex health challenges. We have built malaria prevention and education programmes; a schools-based programme to educate schoolchildren about the importance of hand washing and other hygiene practices; and a programme to address the fear, stigmatisation, discrimination and lack of knowledge that surround HIV and AIDS and stop people coming forward for testing, care and treatment. AMREF understands Africa and we are very happy to work with the UK-based staff who know the programmes and what we are trying to achieve.”
Justine Frain – VP Global Community Partnerships, GlaxoSmithKline